miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis. Wang YD, Wu LL, Mai YN, Wang K, et al. Metabolism 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.

Read + Share

Amedeo Smart

Independent Medical Education

Wang YD, Wu LL, Mai YN, Wang K, et al. miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis. Metabolism 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.
PMID: 37451670